Success Metrics

Clinical Success Rate
85.3%

Based on 29 completed trials

Completion Rate
85%(29/34)
Active Trials
6(13%)
Results Posted
34%(10 trials)
Terminated
5(10%)

Phase Distribution

Ph not_applicable
8
17%
Ph phase_4
6
13%
Ph phase_1
10
21%
Ph phase_3
8
17%
Ph phase_2
16
33%

Phase Distribution

10

Early Stage

16

Mid Stage

14

Late Stage

Phase Distribution48 total trials
Phase 1Safety & dosage
10(20.8%)
Phase 2Efficacy & side effects
16(33.3%)
Phase 3Large-scale testing
8(16.7%)
Phase 4Post-market surveillance
6(12.5%)
N/ANon-phased studies
8(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.3%

29 of 34 finished

Non-Completion Rate

14.7%

5 ended early

Currently Active

6

trials recruiting

Total Trials

48

all time

Status Distribution
Active(8)
Completed(29)
Terminated(5)
Other(6)

Detailed Status

Completed29
unknown6
Recruiting5
Terminated5
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
48
Active
6
Success Rate
85.3%
Most Advanced
Phase 4

Trials by Phase

Phase 110 (20.8%)
Phase 216 (33.3%)
Phase 38 (16.7%)
Phase 46 (12.5%)
N/A8 (16.7%)

Trials by Status

recruiting510%
unknown613%
terminated510%
not_yet_recruiting24%
completed2960%
active_not_recruiting12%

Recent Activity

6 active trials
Showing 5 of 48
recruitingphase_3

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

NCT06679855
recruitingphase_3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT06141473
recruitingphase_2

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

NCT03844061
completedphase_2

Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)

NCT02633163
not_yet_recruitingnot_applicable

Dopamine and Insulin in Psychosis

NCT07252752
View all 48 trials

Clinical Trials (48)

Showing 20 of 48 trialsScroll for more
NCT06679855Phase 3

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

Recruiting
NCT06141473Phase 3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting
NCT03844061Phase 2

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Recruiting
NCT02633163Phase 2

Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)

Completed
NCT07252752Not Applicable

Dopamine and Insulin in Psychosis

Not Yet Recruiting
NCT05136976Phase 3

Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders

Recruiting
NCT07203079Phase 4

Oral Versus Intravenous Acetaminophen in Lumbar Spine Surgery

Not Yet Recruiting
NCT02799212Phase 3

Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma

Completed
NCT01480765Phase 4

Preventing Pain After Heart Surgery

Completed
NCT02525432Phase 2

Autologous Stem Cell Study for Adult TBI (Phase 2b)

Active Not Recruiting
NCT04089579Phase 2

hCT-MSC in Children With Autism Spectrum Disorder

Completed
NCT00248040Phase 2

Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation

Completed
NCT00091637Phase 3

Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)

Completed
NCT04744051Phase 1

ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion

Unknown
NCT03624985Phase 4

The Effect of Perioperative Intravenous Lidocaine Infusion on Opioid Consumption After Lumbar Spine Surgery

Terminated
NCT01670565Phase 2

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Completed
NCT02221219Phase 1

Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury

Completed
NCT04404946Not Applicable

Colloid Co-hydration and Vasoconstrictor Infusion for Prevention of Hypotension During Cesarean Section

Completed
NCT01945840Not Applicable

Gut Hormones and Roux en Y Gastric Bypass

Recruiting
NCT04156035Not Applicable

Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine

Completed

Drug Details

Intervention Type
DRUG
Total Trials
48